Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

A new plant extract from Avicennia marina could potentially be used to treat common hair loss.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Nickel, cobalt, balsam of Peru, fragrance mix, carba mix, and propylene glycol are common allergens causing scalp contact dermatitis.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

A 10-year-old girl with Fox Fordyce disease improved with treatment, suggesting the disease can occur before puberty and might be underdiagnosed in young girls.

Trichotillomania, a disorder where people compulsively pull out their own hair, often starts around age 12, is more common in adult females, and can be treated with behavior therapy and medication.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Hair microscopy is useful for diagnosing certain hair loss conditions but has limitations and must be interpreted carefully.

Intranasal delivery of gene therapy shows promise for treating ischemic stroke.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

A gene in Sebekia benihana, CYP-sb21, is needed for a specific reaction on the drug Cyclosporine A, which could be important for hair growth without affecting the immune system.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

mTORC1 signaling needed for quick hair follicle recovery after radiation damage.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Cosmetic procedures are growing rapidly, with safety and proper techniques being crucial.

Fox Fordyce disease might be more common in prepubertal girls than thought and can be managed with treatment.

Telocytes have potential in therapy and tissue regeneration, but challenges in identification and cultivation remain.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Lipopolysaccharides boost wheat seedling growth, but procyanidin B2 weakens this effect.

Human skin's melanocytes respond to light by changing shape, producing pigments and hormones, which may affect sleep patterns.

Facial hair transplantation has improved to give natural-looking beards and eyebrows with proper technique and patient care.

Rat whisker cells can help turn other cells into nerve cells and might be used to treat brain injuries or diseases.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.